bioRxivCancer BiologyPreprint
Loss of the H4 lysine methyltransferase KMT5B drives tumorigenic phenotypes by depleting H3K27me3 at loci otherwise retained in H3K27M mutant DIPG cells
K. Kessler, A. Mackay, Y. Grabovska, V. Molinari, A. Burford, S. Temelso, H. Tari, E. Yara-Romero, I. Liu, L. Yu, D. Castel, J. Choudhary, A. Sottoriva, M. Filbin, M. Vinci, C. Jones
Abstract
DIPG are characterised by histone H3K27M mutations, resulting in global loss of the repressive mark H3K27me3, although certain key loci are retained. We recently identified subclonal loss-of-function mutations in the H4 lysine methyltransferase KMT5B to be associated with enhanced invasion/migration, but the mechanism by which this occurred was unclear. Here we use integrated ChIP-seq, ATAC-seq and RNA-seq on patient-derived, subclonal and CRISPR-Cas9-KD DIPG cells to show that loss of KMT5B/C causes depletion of these retained H3K27me3 loci via changes in chromatin accessibility, causing a raft of transcriptional changes which promote tumorigenesis. De-repression occurred at bivalent loci marked by H3K4me3, driving increased transcriptional heterogeneity and elevated gene expression associated with increased invasion, abrogated DNA repair and mesenchymal transition, along with a markedly altered secretome. These data suggest a previously unrecognised trans-histone (H4/H3) interaction in DIPG cells with a potentially profound effect on their diffusely infiltrating phenotype.
- organism: human
- assay: ChIP-seq
- assay: ATAC-seq
- assay: bulk RNA-seq
- research focus: cancer & tumor microenvironment
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- H3K27me3-mediated silencing of Wilms Tumor 1 supports the proliferation of brain tumor cells harboring the H3.3K27M mutation
- Disruption of lamina-associated genome organization activates neuronal gene programs in H3.3K27M DIPG
Sajad Hamid Ahanger, Mitchel A. Cole, … Daniel A. Lim·bioRxiv·Sep 22, 2026
- The H3K36me2 writer-reader dependency in H3K27M-DIPG
J.-R. Yu, G. LeRoy, … D. Reinberg·bioRxiv·Jan 6, 2021
- Heterozygous Kmt2d loss diminishes enhancers to render medulloblastoma cells vulnerable to combinatory inhibition of lysine demethylation and oxidative phosphorylation
S. S. Dhar, C. Brown, … M. Lee·bioRxiv·Oct 29, 2023
- KMT5C-H4K20me3 drives changes in epigenetic landscape independent of H3K9me3
Jihye Son, Ching-Hua Shih, … Andrea L. Kasinski·bioRxiv·May 14, 2026
- KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas
J. A. Heward, L. Koniali, … J. Fitzgibbon·bioRxiv·Jun 30, 2020